Flagship Ventures Fund V General Partner LLC

CIK 00017245759 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001724575

Recent Transactions

50 trades

Disposition from Tender
Sigilon Therapeutics, Inc.
Common Stock
2023-08-11$14.92/sh−683,760→ 0 total
Disposition from Tender
Sigilon Therapeutics, Inc.
Common Stock
2023-08-11$14.92/sh−113,960→ 0 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-06-07$6.24/sh−177,240→ 10,743,293 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-06-07$6.24/sh−22,760→ 1,380,277 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-06-06$6.31/sh−181,461→ 10,920,533 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-06-06$6.31/sh−22,297→ 1,403,037 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-26$6.23/sh−9,330→ 1,425,334 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-26$6.23/sh−72,670→ 11,101,994 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-25$6.35/sh−102,245→ 11,174,664 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-25$6.35/sh−13,127→ 1,434,664 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-24$6.57/sh−39,580→ 1,447,791 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-24$6.57/sh−308,290→ 11,276,909 total
Purchase
Codiak BioSciences, Inc.
Common Stock
2022-09-15+722,590→ 1,865,767 total
Purchase
Codiak BioSciences, Inc.
Common Stock
2022-09-15+210,743→ 1,188,920 total
Purchase
Codiak BioSciences, Inc.
Warrants to purchase Common Stock
2022-09-15+722,590→ 722,590 total
Purchase
Codiak BioSciences, Inc.
Warrants to purchase Common Stock
2022-09-15+210,743→ 210,743 total
Conversion
Sana Biotechnology, Inc.$SANA
Series A-2 Convertible Preferred Stock
2021-02-08−1,487,371→ 0 total
Conversion
Sana Biotechnology, Inc.$SANA
Series A-2 Convertible Preferred Stock
2021-02-08−11,441,326→ 0 total
Conversion
Sana Biotechnology, Inc.$SANA
Series A-2 Convertible Preferred Stock
2021-02-08−11,585,199→ 0 total
Conversion
Sana Biotechnology, Inc.$SANA
Series A-2 Convertible Preferred Stock
2021-02-08−9,725,122→ 0 total
Conversion
Sana Biotechnology, Inc.$SANA
Common Stock
2021-02-08+1,487,371→ 1,487,371 total
Conversion
Sana Biotechnology, Inc.$SANA
Common Stock
2021-02-08+9,725,122→ 9,725,122 total
Conversion
Sana Biotechnology, Inc.$SANA
Common Stock
2021-02-08+11,441,326→ 11,441,326 total
Conversion
Sana Biotechnology, Inc.$SANA
Common Stock
2021-02-08+11,585,199→ 11,585,199 total
Conversion
Sigilon Therapeutics, Inc.
Common Stock
2020-12-08+8,888,888→ 8,888,888 total
Conversion
Sigilon Therapeutics, Inc.
Series B Convertible Preferred Stock
2020-12-08−1,481,481→ 0 total
Conversion
Sigilon Therapeutics, Inc.
Series A-1 Convertible Preferred Stock
2020-12-08−4,074,074→ 0 total
Conversion
Sigilon Therapeutics, Inc.
Series B Convertible Preferred Stock
2020-12-08−370,370→ 0 total
Conversion
Sigilon Therapeutics, Inc.
Common Stock
2020-12-08+1,481,481→ 1,481,481 total
Conversion
Sigilon Therapeutics, Inc.
Series A Convertible Preferred Stock
2020-12-08−4,444,444→ 0 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Series B Convertible Preferred Stock
2020-10-27−1,336,293→ 0 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2020-10-27+4,054,054→ 4,054,054 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2020-10-27+4,504,504→ 8,558,558 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2020-10-27+722,320→ 9,280,878 total
Purchase
Foghorn Therapeutics Inc.$FHTX
Common Stock
2020-10-27$16.00/sh+50,000→ 9,330,878 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2020-10-27+1,441,441→ 1,441,441 total
Purchase
Foghorn Therapeutics Inc.$FHTX
Common Stock
2020-10-27$16.00/sh+50,000→ 1,491,441 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2020-10-27+1,801,801→ 1,801,801 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Series A-2 Convertible Preferred Stock
2020-10-27−8,333,333→ 0 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Series B Convertible Preferred Stock
2020-10-27−2,666,666→ 0 total
Purchase
Foghorn Therapeutics Inc.$FHTX
Common Stock
2020-10-27$16.00/sh+50,000→ 1,851,801 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Series A-1 Convertible Preferred Stock
2020-10-27−7,500,000→ 0 total
Conversion
Foghorn Therapeutics Inc.$FHTX
Series B Convertible Preferred Stock
2020-10-27−3,333,333→ 0 total
Conversion
Codiak BioSciences, Inc.
Series B Preferred Stock
2020-10-16−2,416,666→ 0 total
Conversion
Codiak BioSciences, Inc.
Common Stock
2020-10-16+338,630→ 882,316 total
Conversion
Codiak BioSciences, Inc.
Series A Preferred Stock
2020-10-16−4,250,000→ 0 total
Conversion
Codiak BioSciences, Inc.
Common Stock
2020-10-16+543,686→ 543,686 total
Conversion
Codiak BioSciences, Inc.
Common Stock
2020-10-16+338,630→ 882,316 total
Conversion
Codiak BioSciences, Inc.
Common Stock
2020-10-16+95,861→ 978,177 total
Conversion
Codiak BioSciences, Inc.
Common Stock
2020-10-16+543,686→ 543,686 total

Companies

Recent Filings

Address

55 CAMBRIDGE PARKWAY, SUITE 800E

CAMBRIDGE, MA, 02142

View on SEC.gov